PAS: Balanced Crystalloid Fluid, 0.9 Percent Saline Comparable in Pediatric Septic Shock

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 29, 2026.

via HealthDay

WEDNESDAY, April 29, 2026 -- For children treated for suspected septic shock, the incidence of death, new renal-replacement therapy, or persistent kidney dysfunction is similar with fluid resuscitation administered with balanced crystalloid fluid or 0.9 percent saline, according to a study published online April 23 in the New England Journal of Medicine to coincide with the annual meeting of the Pediatric Academic Societies, being held April 24 to 27 in Boston.

Fran Balamuth, M.D., Ph.D., from the Children's Hospital of Philadelphia, and colleagues conducted a pragmatic clinical trial at 47 emergency departments in five countries involving children aged 2 months to <18 years of age with suspected septic shock and abnormal perfusion. Participants were randomly assigned to receive fluid resuscitation with either balanced fluid or 0.9 percent saline for up to 48 hours (4,235 and 4,247 patients, respectively, were included in the analysis). The primary outcome was a major adverse kidney event (composite of death, new renal-replacement therapy, or persistent kidney dysfunction) at 30 days after enrollment or hospital discharge.

The researchers found that a primary outcome event occurred in 3.4 and 3.0 percent of patients in the groups receiving balanced fluid and 0.9 percent saline, respectively. During the 28 days after enrollment, the median number of hospital-free days was 23 in both groups. Hyperchloremia occurred in 31.4 and 49.0 percent of patients in the groups receiving balanced fluid and 0.9 percent saline, respectively; hypernatremia occurred in 1.8 and 3.1 percent, respectively; and hyperlactatemia occurred in 19.8 and 16.7 percent, respectively. There were no differences seen in other safety outcomes or adverse events.

"In an emergency department with a child with suspected sepsis, you can treat the child with whichever fluid is readily available," Balamuth said in a statement. "And we think that's great news for children around the world."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords